idiopathic macular hole (MH) surgery
ProcedureIdiopathic Macular Hole Surgery with Different Internal Limiting Membrane Peeling Patterns
NCT Number: NCT04655781
The purpose of this study is to investigate displacement of the retina after idiopathic macular hole surgery with different internal limiting membrane peeling patterns.
Looking for future studies?
Notify Me10 year–80 year
All sexes
Interventional
Not applicable
After being informed about the study and potential risks, all patients giving written informed consent will undergo a 1-week screening period to determine eligibility for study entry. All patients with idiopathic MH will be randomly allocated into two groups, N-T group or T-N group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Eyes with idiopathic macular hole
Exclusion criteria
Eyes having re-do macular hole surgery, with high myopia, with proliferative vitreoretinopathy or with a retinal detachment combined with the MH, with other macular diseases, such as age-related macular degeneration.
Idiopathic Macular Hole Surgery with Different Internal Limiting Membrane Peeling Patterns
Time frame: preoperation to postoperative 6 months
measurement of temporal vessel to optic disc
The First Affiliated Hospital with Nanjing Medical University
Other
Displacement of the Retina After Idiopathic Macular Hole Surgery With Different Internal Limiting Membrane Peeling Patterns
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04278079
Internal Limiting Membrane Peeling, Myopic Traction Maculopathy
View Trial Details